News

Press Releases

Nov 12, 2020

Neurotech appoints John Pollack, M.D. as Chief Medical Officer

View PDF Version

Nov 6, 2020

Rich Small, Chief Executive Officer presents at Eyecelerator 2020 Virtual Conference

Sep 30, 2020

Rich Small, Chief Executive Officer presents at Ophthalmology Futures Retina Forum

Feb 12, 2019

Neurotech Pharmaceuticals, Inc. Granted Fast Track

Neurotech Pharmaceuticals, Inc. Granted Fast Track Designation from the U.S. FDA for the Treatment of Macular Telangiectasia type 2. View...

Jan 16, 2019

Neurotech Announces Publication of NT-501 Phase 2 Results.

View PDF Version

Learn more and get updates on Neurotech Pharmaceuticals corporate and how we deliver MacTel treatment solutions,
MacTel clinical trials, and MacTel Implant Encapsulated Cell Therapy.